Schedule 2 Categories of goods posing a low risk exempted from routine checks at border control posts
Table 1
Animal by-products and derived products
| Product | Intended use of the product in Great Britain | Additional conditions and permitted countries |
|---|---|---|
| (1) Product is intended to be used as a stabiliser or carrier for any of— | ||
| — monoclonal antibodies, polyclonal antibodies, proteins, enzymes, peptides and polypeptides separated from plasma or serum and purified to the extent that they do not contain any viable pathogenic micro-organisms; | ||
| — cells which do not contain a pathogen; | ||
| — cell cultures which are more than one generation removed from tissue harvested from an animal; | ||
| — stem cells derived from animals born and reared exclusively in a laboratory environment; and | ||
| — material other than animal by-products or derived products. | ||
| (2) The animal by-product used as the stabiliser or carrier— | ||
| — is at a concentration of either 3% or less of the entire product, with no limit on the individual unit size, or a percentage greater than 3% but no more than 10% of the entire product, with a maximum individual unit size of 100 ml; | ||
| — is intended for laboratory or pharmaceutical use only; and | ||
| — is not for any subsequent use other than as a carrier or stabliser. | ||
| Apiculture by-products | For use other than in apiculture. | Must meet the requirements in entry 10 of Table 2 (apiculture by-products) in Section 1 of Chapter 2 of Annex 14 to Regulation 142/2011. |
| Collagen | Other than as feed material. | The product must—
|
| Dicalcium phosphate | Other than as feed material. | The product must—
|
| Fish oil | Other than as feed material. | The product must come from a country listed—
|
| Gelatine, other than photogelatine | Other than as feed material. | The product must—
|
| Highly processed derived products from animal by-products in a category specified in Chapter 1, section 1, Table 1 or in Chapter 2, section 1, Table 2 of Annex 1 to Regulation 142/2011 | For use as laboratory reagents and pharmaceutical use, including in the manufacture of pharmaceuticals and laboratory reagents. | The product must—
|
| Hydrolysed protein | Other than as feed material. | The product must—
|
| Intermediate products | Use as specified in paragraph 35 of Annex 1 to Regulation 142/2011. | The product must—
|
| Treated blood products, other than from equidae | Other than as feed material; for in-vitro use only, for the manufacture of derived products for uses outside the feed chain for farmed animals. | The product—
|
| Treated feathers, parts of feathers and down | Other than as feed material. | Must meet the requirements in entry 9 of Table 2 (treated feathers) in Section 1 of Chapter 2 of Annex 14 to Regulation 142/2011. |
| Treated milk and milk-based products and treated blood products | For use only as a stabiliser or carrier for materials specified in Note f2. | The animal by-product used as the stabiliser or carrier must meet the conditions specified in Note f3. The product must—
|
Table 2
Low risk products of animal origin from permitted countries
| 1. Commodity | 2. Conditions for inclusion in low risk category | 3. Comments |
|---|---|---|
| Apiculture products for human consumption | Low risk for Argentina, Australia, Brazil, Canada, Chile, India, New Zealand, Ukraine, United States, Uruguay and Vietnam. | Must come from a country—
|
| Bovine meat and meat products | Low risk for chilled or fresh meat and meat products from New Zealand. As regards New Zealand and any other permitted country which has a negligible or controlled BSE status: low risk if shelf stable at ambient temperature and sterilised. | Fresh meat and meat products must meet the relevant requirements of Regulation 853/2004. Fresh meat and meat used to make meat products must meet the requirements for fresh meat in Regulation 206/2010 and come from a country listed in Annex 1 to Regulation 206/2010 and specified in a document published by the Secretary of State for the purposes of Article 3a of that Regulation. Bovine meat products must—
|
| Composite products, other than those containing bivalve molluscs, echinoderms, tunicates or marine gastropods or their products. | As regards all permitted countries, low risk if shelf stable at ambient temperature and sterilised. | Composite products (other than those otherwise exempted from official controls under Article 6 of Decision 2007/275, or by listing in accordance with Article 3(1)(b) of Decision 2007/275) must—
|
| Dairy products and colostrum-based products which are preserved at frozen or chilled temperatures. | Low risk for Canada and New Zealand only. Products must only contain milk which has been subject to pasteurisation or an equivalent or higher level of treatment (eg UHT processing). | Products must meet the requirements of Regulations 605/2010 and 853/2004 and of any assimilated direct minor legislation or regulations made under those Regulations. |
| Dairy products and colostrum-based products (other than those preserved at frozen or chilled temperatures). | Low risk for Canada and New Zealand if shelf-stable at ambient temperature. Low risk for all permitted countries if shelf stable at ambient temperature and sterilised. | Goods in this category must—
|
| Egg products | Low risk for the USA if shelf-stable at ambient temperature. | Goods in this category must meet the requirements of Regulation 798/2008, Regulation 853/2004 and any assimilated direct minor legislation or regulations made under those Regulations. |
| Fishery products, including crustaceans | Low risk for New Zealand, except for species of the families of Scombridae, Clupeidae, Engraulidae, Corfenidae, Pomatomidae or Scombresosidae (“histamine susceptible species”), except for fishery products from aquaculture. Low risk, with the exception of histamine susceptible species, bivalve molluscs, echinoderms, tunicates or marine gastropods, for all permitted countries if shelf stable at ambient temperature and sterilised | Goods in this category must meet the applicable requirements of Regulations 852/2004, 853/2004 and 1251/2008. Country of origin must be listed in Annex 2 of Regulation 2019/626. Must meet the requirements for fishery products in Regulation 2019/628. |
| Gelatine and collagen | Low risk for bovine products from permitted countries where BSE risk is negligible or controlled. Low risk for non-bovine products from all permitted countries. | Must meet the applicable requirements of Regulations 852/2004, 853/2004 and 2019/628. For gelatine and collagen derived from bovine or ovine animals—
|
| Highly refined products of animal origin | Low risk for all permitted countries. | Must meet the relevant requirements of Regulation 2019/628 and Regulation 853/2004. |
| Honey | Low risk for Argentina, Australia, Brazil, Canada, Chile, India, New Zealand, Ukraine, United States, Uruguay and Vietnam. | Must come from a country—
|
| Milk | Low risk for all permitted countries if shelf stable at ambient temperature and sterilised. | Goods in this category must—
|
| Ovine, caprine and camelid meat and meat products | Low for fresh meat and meat products from Australia. Low risk for all permitted countries if shelf stable at ambient temperature and sterilised. | Fresh meat or meat products in this category imported from Australia must meet the requirements applicable to fresh meat in Regulation 206/2010. For meat products which are shelf stable at ambient temperature—
|
| Porcine meat and meat products | Low risk for all permitted countries if shelf stable at ambient temperature and sterilised. | Must meet the requirements of Regulation 853/2004 and Decision 2007/777, and of any applicable assimilated direct minor legislation or regulations made under Regulation 853/2004. |
| Poultry meat and poultry meat products | Low risk for all permitted countries if shelf stable at ambient temperature and sterilised. Poultry meat products must not originate in China or Thailand. | Must—
|
| Rabbit meat, game meat and rabbit and game meat products | Low risk for all permitted countries if shelf stable at ambient temperature and sterilised. | Must meet the requirements of Regulations 853/2004 and Decision 2007/777, and of any applicable assimilated direct minor legislation or regulations made under Regulation 853/2004. Must—
|
| Rendered animal fat and greaves | Low risk for bovine products from permitted countries where the BSE risk is negligible or controlled. Low risk for non-bovine products from all permitted countries. | Must—
|
| Soliped meat and meat products | Low risk for all permitted countries if shelf stable at ambient temperature and sterilised. | Must—
|
Table 3
Permitted countries
| Country or region |
|---|
| Argentina |
| Australia |
| Botswana |
| Brazil |
| Canada |
| Chile |
| China |
| Ecuador |
| India |
| Israel |
| Japan |
| Namibia |
| New Zealand |
| Nicaragua |
| Singapore |
| South Africa |
| South Korea |
| Thailand |
| Turkey |
| Ukraine |
| United States |
| Uruguay |
| Vietnam |
In this Schedule—
-
“BSE risk status” refers to the risk statusf6—
-
“collagen” has the meaning given by—
- (a)
in relation to animal by-products, point 11 of Annex 1 to Regulation 142/2011f9; and
- (b)
in relation to products of animal origin, point 7.8 of Annex 1 to Regulation 853/2004;
- (a)
-
“composite product” has the meaning given by Article 2(a) of Decision 2007/275 concerning lists of composite products to be subject to controls at border control posts;
-
“egg products” has the meaning given by point 7.3 of Annex 1 to Regulation 853/2004;
-
“F0 value” means the thermal lethality time required to eliminate all microorganisms present in foods, by exposing them to a temperature of 121.1o C, expressed in minutes;
-
“feed material” means—
- (a)
feed material as defined in point 3 of Annex 1 to Regulation 142/2011; and
- (b)
petfood;
- (a)
-
“fish oil” has the meaning given by point 9 of Annex 1 to Regulation 142/2011;
-
“fishery products” has the meaning given by point 3.1 of Annex 1 to Regulation 853/2004;
-
“fresh meat” means fresh meat as defined in point 1.10 of Annex 1 to Regulation 853/2004;
-
“gelatine” has the meaning given—
- (a)
in relation to animal by-products, by point 12 of Annex 1 to Regulation 142/2011; or
- (b)
in relation to products of animal origin, by point 7.7 of Annex 1 to Regulation 853/2004;
- (a)
-
“greaves” has the meaning given—
- (a)
in relation to animal by-products, by point 13 of Annex 1 to Regulation 142/2011; or
- (b)
in relation to products of animal origin, by point 7.6 of Annex 1 to Regulation 853/2004;
- (a)
-
“highly refined products of animal origin” means—
- (a)
chondroitin sulphate;
- (b)
hyaluronic acid;
- (c)
other hydrolysed cartilage products;
- (d)
chitosan;
- (e)
glucosamine;
- (f)
rennet;
- (g)
isinglass; and
- (h)
amino acids that are authorised as food additives in accordance with Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additivesf10.
- (a)
-
“honey” means the natural sweet substance produced by Apis mellifera bees from the nectar of plants or from secretions of living parts of plants or excretions of plant-sucking insects on the living parts of plants, which the bees collect, transform by combining with specific substances of their own, deposit, dehydrate, store and leave in honeycombs to ripen and mature;
-
“hydrolysed protein” has the meaning given by point 14 of Annex 1 to Regulation 142/2011;
-
“intermediate product” has the meaning given by point 35 of Annex 1 to Regulation 142/2011, and for the purposes of that definition “derived product” is to be construed in accordance with Article 3.2 of Regulation 1069/2009;
-
“laboratory reagent” has the meaning given by point 36 of Annex 1 to Regulation 142/2011;
-
“meat products” has the meaning given by point 7.1 of Annex 1 to Regulation 853/2004;
-
“permitted countries” means those countries listed in Table 3;
-
“petfood” has the meaning given by point 19 of Annex 1 to Regulation 142/2011;
-
“photogelatine” means gelatine which has been produced from material containing bovine vertebral column in accordance with Article 8(b) of Regulation 1069/2009 and which is intended for the photographic industry;
-
“Regulation 999/2001” means Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathiesf11;
-
“Regulation 852/2004” means Regulation (EC) No 852/2004 of the European Parliament and of the Council on the hygiene of foodstuffsf12;
-
“specified risk material” means the material referred to in Article 8 of, and listed in Annex 5 to, Regulation 999/2001f13;
-
“sterilised” in relation to a product, means that the product has been sterilised either by undergoing specific treatment in a hermetically sealed container that achieves an F0 value of three or more or by undergoing heat treatment, prior to aseptic packaging, that achieves commercial sterilisation;
-
“treated blood products” means blood products, as defined in point 4 of Annex 1 to Regulation 142/2011, which meet the specific requirements listed for such products in Chapter 2, Section 1 of Annex 14 to that Regulation;
-
“treated feathers” means feathers or parts of feathers which have been treated with a steam current or by a method that ensures that no risks to human or animal health or to the environment remain.
Annotations
Footnotes
- f1
-
A list of members can be found on the website of the World Organisation for Animal Health at Members - WOAH - World Organisation for Animal Health.
- f2
(1)
Product is intended to be used as a stabiliser or carrier for any of—
- f3
(2)
The animal by-product used as the stabiliser or carrier—
- f4
-
Article 6(2) of Commission Decision 2007/275 refers to the countries listed in Annex 1 of Regulation 605/2010. However, Article 3 of, and Annex 1 to, Regulation 605/2010 were amended by S.I. 2022/735 to require such of those countries or parts of countries listed in Annex 1 from which milk, dairy products, colostrum and colostrum-based products are to be authorised by the appropriate authority for importation to be specified in a document published by the Secretary of State.
- f5
-
Article 5 of Decision 2007/777 was amended by S.I. 2020/1462 and 2022/735.
- f6
-
The reference to a country’s BSE status is to the status of a country determined in accordance with Article 5 of Regulation 999/2001 of the European Parliament and the Council, laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies. Details of each country’s BSE status are included in the document entitled “Bovine Spongiform Encephalopathy (BSE) risk status of trading partners”, published by the Secretary of State on 10th February 2023 in accordance with Article 5(7B) of that Regulation. This document can be found at. bse.pdf (amazonaws.com) and a hard copy of that document may be inspected at DEFRA, Seacole Building, 2 Marsham Street, London SW1P 4DF.
- f7
-
EUR 999/2001. Article 5 was amended by S.I. 2019/170 (as amended by S.I. 2020/1388), 2019/588 (as amended by S.I. 2020/1463), 2020/1388 and 2022/735.
- f8
-
The document referred to in Article 5(7B) is published online and can be found at Animal health status of countries approved to export animals and animal products to Great Britain - data.gov.uk. A hard copy of that document may be inspected at DEFRA, Seacole Building, 2 Marsham Street, London SW1P 4DF.
- f9
-
EUR 142/2011. Annex 1 was amended by S.I. 2020/1388.
- f10
-
EUR 2008/1333, as amended by S.I. 2019/860.
- f11
-
EUR 999/2001, amended by S.I. 2019/170 (as amended by S.I. 2019/1220 and 2020/1388), 2019/588 (as amended by S.I. 2020/1463), 1220 and 1229, 2020/1388 and1463, 2021/1229, 2022/735, 1090 and 1315.
- f12
-
EUR 852/2004, amended by S.I. 2019/642 (as amended by S.I. 2020/1504) and 2023/959.
- f13
-
Article 8 was amended by S.I. 2019/170 (as amended by S.I 2020/1388), 2019/588 (as amended by S.I. 2020/1463) and 2020/1388.